Human Investing’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.72M | Sell |
2,265
-59
| -3% | -$60.3K | 0.35% | 26 |
|
|
2026
Q1 | $2.14M | Buy |
2,324
+17
| +0.7% | +$17.2K | 0.31% | 27 |
|
|
2025
Q4 | $2.48M | Sell |
2,307
-13
| -0.6% | -$12.4K | 0.35% | 26 |
|
|
2025
Q3 | $1.77M | Sell |
2,320
-5
| -0.2% | -$3.72K | 0.26% | 29 |
|
|
2025
Q2 | $1.81M | Buy |
2,325
+2
| +0.1% | +$1.55K | 0.29% | 29 |
|
|
2025
Q1 | $1.92M | Hold |
2,323
| – | – | 0.34% | 28 |
|
|
2024
Q4 | $1.79M | Sell |
2,323
-365
| -14% | -$302K | 0.32% | 29 |
|
|
2024
Q3 | $2.38M | Sell |
2,688
-74
| -3% | -$66.5K | 0.43% | 29 |
|
|
2024
Q2 | $2.5M | Buy |
2,762
+2
| +0.1% | +$1.6K | 0.49% | 27 |
|
|
2024
Q1 | $2.15M | Sell |
2,760
-23
| -0.8% | -$16.4K | 0.43% | 30 |
|
|
2023
Q4 | $1.62M | Sell |
2,783
-365
| -12% | -$213K | 0.35% | 30 |
|
|
2023
Q3 | $1.69M | Sell |
3,148
-63
| -2% | -$32.5K | 0.39% | 31 |
|
|
2023
Q2 | $1.51M | Sell |
3,211
-179
| -5% | -$75.1K | 0.34% | 30 |
|
|
2023
Q1 | $1.16M | Sell |
3,390
-110
| -3% | -$37.1K | 0.28% | 36 |
|
|
2022
Q4 | $1.28M | Sell |
3,500
-1,178
| -25% | -$418K | 0.33% | 35 |
|
|
2022
Q3 | $1.51M | Sell |
4,678
-119
| -2% | -$37.7K | 0.39% | 37 |
|
|
2022
Q2 | $1.55M | Sell |
4,797
-314
| -6% | -$94.3K | 0.38% | 38 |
|
|
2022
Q1 | $1.46M | Buy |
+5,111
| New | +$1.32M | 0.32% | 44 |
|
|
2021
Q4 | – | Sell |
-5,554
| Closed | -$1.28M | – | 96 |
|
|
2021
Q3 | $1.28M | Sell |
5,554
-1,289
| -19% | -$318K | 0.3% | 47 |
|
|
2021
Q2 | $1.57M | Sell |
6,843
-301
| -4% | -$60.5K | 0.38% | 41 |
|
|
2021
Q1 | $1.33M | Sell |
7,144
-1,378
| -16% | -$270K | 0.34% | 45 |
|
|
2020
Q4 | $1.44M | Sell |
8,522
-136
| -2% | -$20.3K | 0.41% | 41 |
|
|
2020
Q3 | $1.28M | Sell |
8,658
-5,478
| -39% | -$848K | 0.42% | 58 |
|
|
2020
Q2 | $2.32M | Sell |
14,136
-1,681
| -11% | -$258K | 0.82% | 23 |
|
|
2020
Q1 | $2.19M | Buy |
15,817
+3,527
| +29% | +$485K | 0.95% | 16 |
|
|
2019
Q4 | $1.61M | Buy |
12,290
+138
| +1% | +$16K | 0.53% | 52 |
|
|
2019
Q3 | $1.36M | Sell |
12,152
-216
| -2% | -$24K | 0.48% | 65 |
|
|
2019
Q2 | $1.37M | Sell |
12,368
-515
| -4% | -$60.6K | 0.5% | 64 |
|
|
2019
Q1 | $1.67M | Sell |
12,883
-12,901
| -50% | -$1.57M | 0.62% | 46 |
|
|
2018
Q4 | $2.98M | Buy |
+25,784
| New | +$2.88M | 1.24% | 13 |
|
Other funds holding LLY
Human Investing's LLY Position: Q2 2026 in Review
Human Investing reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2026, selling an estimated $60.3K and leaving 2,265 shares worth $2.72M. The position accounts for 0.35% of the portfolio, ranked #26.
Human Investing first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.98M in Q4 2018. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Human Investing held 2,265 shares of Eli Lilly worth $2.72M as of Q2 2026.
- Human Investing sold 59 Eli Lilly shares in Q2 2026, an estimated $60.3K.
- Eli Lilly made up 0.35% of Human Investing's portfolio in Q2 2026, its #26 holding.
- Human Investing first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
- Human Investing's Eli Lilly position peaked at $2.98M in Q4 2018.
- 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Human Investing's 13F filing for Q2 2026, filed 20 Jul 2026.